Ad-hoc | 17 July 2007 16:35


Eckert & Ziegler: Additional burden of approx. 0.25 EUR per share due to corporate tax reform

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Profit Warning

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------

The corporate tax reform adopted by the German federal government will
amount to an additional non-monetary burden of 0.25 EUR per share for the
2007 Annual Report of the Berlin-based company Eckert & Ziegler Strahlen-
und Medizintechnik AG, according to an estimate released today. This is
because the reform requires a reevaluation of active and passive latent tax
items on the balance sheet, especially losses carried forward. Due to lower
income tax levels in the future, their value is reduced by approx. 0.8
million EUR.

This balance sheet correction does not affect the anticipated result before
special effects from the corporate tax reform, which remains unchanged at
0.90 EUR per share for the current year.

The Board


Eckert & Ziegler AG
Thomas Scheuch, Investor Relations, Robert-Rössle-Str. 10, D-13125 Berlin
phone: +49 (0) 30 / 94 10 84-139; fax -112; e-mail: thomas.scheuch@ezag.de;
www.ezag.de


DGAP 17.07.2007 
----------------------------------------------------------------------
 
Language:     English
Issuer:       ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
              Robert-Rössle-Str. 10
              13125 Berlin Deutschland
Phone:        +49 (0)30 941 084-0
Fax:          +49 (0)30 941 084-112
E-mail:       thomas.scheuch@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700
WKN:          565970
Indices:      
Listed:       Geregelter Markt in Frankfurt (Prime Standard), Stuttgart;
              Freiverkehr in Berlin, München, Hamburg, Düsseldorf
 
End of News                                     DGAP News-Service
 
---------------------------------------------------------------------------